Medical Equipment

Global Organoid Kit Market Set for Strong Expansion Reaching $2.74 Billion by 2030 at 15.9% CAGR

March 16, 2026March 16, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Valuation Is Forecasted For The Organoid Kit Market By 2030 Starting From Its 2026 Size?

The organoid kit market size has seen rapid expansion in recent years. It will grow from $1.31 billion in 2025 to $1.52 billion in 2026 at a compound annual growth rate (CAGR) of 16.2%. This historical growth can be attributed to factors such as advancements in stem cell research, the increasing adoption of these kits in drug discovery, the development of standardized kits, an expansion in biomedical research, and increased funding for organoid studies.

The organoid kit market size is anticipated to undergo significant expansion over the next few years. It is forecast to grow to $2.75 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 15.9%. This projected increase during the forecast period is primarily due to the broadening scope of personalized medicine, the integration of artificial intelligence into organoid analysis, enhancements in microfluidics platforms, the expanding applications of regenerative medicine, and a rise in collaborations between pharmaceutical and biotech companies. Noteworthy trends for this period include advancements in 3D cell culture, the development of personalized organoids, microfluidics-based organoid platforms, organoid bioprinting technology, and disease modeling using stem cells.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28286&type=smp

What Drivers Are Shaping The Future Growth Of The Organoid Kit Market?

The projected expansion of the organoid kit market is anticipated to be driven by the rising occurrence of infectious diseases. These diseases are defined as ailments resulting from pathogenic microorganisms, including bacteria, viruses, fungi, or parasites, capable of direct or indirect transmission between individuals. The surge in infectious diseases stems from inadequate sanitation and high population density, facilitating easier pathogen transmission and elevated infection rates. Organoid kits play a crucial role in combating infectious diseases by empowering researchers to create human tissue models in laboratory settings, thereby enabling detailed investigation of pathogen conduct, infection processes, and the evaluation of prospective therapies. An illustrative example is from August 2024, where data released by the UK Health Security Agency, a UK-based executive agency, indicated that in England, the UK Health Security Agency (UKHSA) recorded 368 measles cases in 2023. This represented a nearly sevenfold increase compared to the 53 cases documented in 2022, with the West Midlands and London collectively responsible for 44% and 33% of these cases, respectively. Consequently, the rising frequency of infectious diseases is fueling the expansion of the organoid kit market.

Which Segment Categories Define The Organoid Kit Market?

The organoid kit market covered in this report is segmented –

1) By Type: Brain Organoids, Kidney Organoids, Intestinal Organoids, Liver Organoids, Other Organoid Types

2) By Technology: 3D Cell Culture Technology, Microfluidics Technology

3) By Source: Human-Derived Organoids, Animal-Derived Organoids, Cell Line-Derived Organoids

4) By Application: Drug Discovery and Development, Disease Modeling, Personalized Medicine, Other Applications

5) By End-User: Research Institutes, Pharmaceutical Companies, Contract Research Organizations, Biotech Companies

Subsegments:

1) By Brain Organoids: Cerebral Organoids, Midbrain Organoids, Retinal Organoids

2) By Kidney Organoids: Nephron Organoids, Collecting Duct Organoids, Glomerular Organoids

3) By Intestinal Organoids: Small Intestine Organoids, Colon Organoids, Gastric Organoids

4) By Liver Organoids: Hepatic Organoids, Cholangiocyte Organoids, Biliary Organoids

5) By Other Organoid Types: Pancreatic Organoids, Lung Organoids, Heart Organoids, Tumor Organoids

What Major Market Trends Are Driving Changes In The Organoid Kit Market?

Major companies within the organoid kit market are concentrating on developing rapid aggregate formations. This initiative aims to accelerate organoid development schedules, enhance reproducibility, and enable high-throughput applications for advancements in drug discovery, disease modeling, and personalized medicine. Rapid aggregate formation describes the capacity to swiftly produce thousands of uniform pluripotent stem cell aggregates within a single day, thereby significantly reducing the overall organoid development time. For example, in June 2025, Pluristyx Inc., a US-based biotechnology company, unveiled its PluriForm Organoid Kit. This product was specifically designed to simplify the creation of pluripotent stem cell aggregates and to speed up organoid development processes. The kit presents a ready-to-use platform that shortens the necessary timeline for generating mature organoids from several months to merely weeks. It integrates optimized growth media along with standardized protocols, which guarantees reproducible results across a variety of cell types. Moreover, the kit supports high-throughput applications, making it well-suited for large-scale disease modeling and comprehensive drug screening efforts.

Who Are The Top Companies Competing In The Organoid Kit Market?

Major companies operating in the organoid kit market are STEMCELL Technologies Inc., Bio-Techne Corporation, Takara Bio Inc., American Type Culture Collection (ATCC), ACROBiosystems Inc., MIMETAS B.V., Emulate Inc., CN Bio Innovations Limited, InSCREENeX GmbH, TheWell Bioscience Inc., Prellis Biologics Inc., Crown Bioscience International, AMS Biotechnology (Europe) Limited (AMSBIO), Xylyx Bio Inc., Organovo Holdings Inc., HUB Organoids Holding B.V., Cellesce Ltd., DefiniGEN Ltd., OcellO B.V., AlveoliX AG, VitroLabs Inc.

Read the full organoid kit market report here:

https://www.thebusinessresearchcompany.com/report/organoid-kit-global-market-report

Which Geographic Regions Are Influencing Demand In The Organoid Kit Market?

North America was the largest region in the organoid kit market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the organoid kit market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Organoid Kit Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=28286&type=smp

Browse Through More Reports Similar to the Global Organoid Kit Market 2026, By The Business Research Company

Organoids And Spheroids Market Report 2026

https://www.thebusinessresearchcompany.com/report/organoids-and-spheroids-global-market-report

Artificial Organ Market Report 2026

https://www.thebusinessresearchcompany.com/report/artificial-organ-global-market-report

Artificial Organ And Bionics Market Report 2026

https://www.thebusinessresearchcompany.com/report/artificial-organ-and-bionics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795